ACE variants and association with brain Aβ levels in Alzheimer's disease

被引:0
|
作者
Miners, J. Scott [1 ]
van Helmond, Zoe [1 ]
Raiker, Merryn [1 ]
Love, Seth [2 ]
Kehoe, Patrick G. [1 ]
机构
[1] Univ Bristol, Inst Clin Neurosci, Dementia Res Grp, Bristol BS16 1LE, Avon, England
[2] Univ Bristol, Inst Clin Neurosci, Dept Neuropathol, Bristol BS16 1LE, Avon, England
来源
关键词
Alzheimer's disease; angiotensin; ACE; amyloid; neuropathology; soluble A beta; insoluble A beta; SNP; association; A beta degrading enzyme; cerebral blood flow; hypertension;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ACE is a candidate gene for Alzheimer's disease (AD) and associations have been reported between ACE variants and plasma ACE levels, AD risk, AD age at onset of disease and cerebrospinal fluid levels of A beta. Despite evidence that ACE can degrade A beta, the relationships between ACE variants and the levels of different types of A beta in the brain are not known. We have investigated the relationship between AD-associated ACE variants, for which the associations with brain activity of ACE were previously analysed, and brain homogenate levels of soluble, insoluble and oligomeric A beta. Reported AD risk variants in the ACE indel (rs1799752) and its 'proxy' rs4343 were significantly associated with soluble A beta level in AD only (p=0.001), as was rs1800764 but less so (p=0.014). In contrast, insoluble A beta was associated with ACE indel and rs4343 variants in controls only (p < 0.01). No associations were found for oligomeric A beta. These data indicate a complex relationship between ACE and A beta that differs between AD and control brains.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 50 条
  • [21] Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease
    Louise Reveret
    Manon Leclerc
    Vincent Emond
    Cyntia Tremblay
    Andréanne Loiselle
    Philippe Bourassa
    David A. Bennett
    Sébastien S. Hébert
    Frédéric Calon
    Acta Neuropathologica Communications, 11
  • [22] Association of rare variants in neurodegenerative genes with familial Alzheimer's disease
    Zhang, Weiwei
    Jiao, Bin
    Xiao, Tingting
    Liu, Xixi
    Liao, Xinxin
    Xiao, Xuewen
    Guo, Lina
    Yuan, Zhenhua
    Yan, Xinxiang
    Tang, Beisha
    Shen, Lu
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (10): : 1985 - 1995
  • [23] Association of SORL1 gene variants with Alzheimer's disease
    Koelsch, Heike
    Jessen, Frank
    Wiltfang, Jens
    Lewczuk, Piotr
    Dichgans, Martin
    Teipel, Stefan J.
    Kornhuber, Johannes
    Froelich, Lutz
    Heuser, Isabella
    Peters, Oliver
    Wiese, Birgitt
    Kaduszkiewicz, Hanna
    van den Bussche, Hendrik
    Huell, Michael
    Kurz, Alexander
    Ruether, Eckhart
    Henn, Fritz A.
    Maier, Wolfgang
    BRAIN RESEARCH, 2009, 1264 : 1 - 6
  • [24] Brain-Derived Neurotrophic Factor Gene Variants and Alzheimer Disease: An Association Study in an Alzheimer Disease Italian Population
    Boiocchi, Chiara
    Maggioli, Elisa
    Zorzetto, Michele
    Sinforiani, Elena
    Cereda, Cristina
    Ricevuti, Giovanni
    Cuccia, Mariaclara
    REJUVENATION RESEARCH, 2013, 16 (01) : 57 - 66
  • [25] Association of PTHrP levels in CSF with Alzheimer's disease biomarkers
    Kushnir, Mark M.
    Michno, Wojciech
    Rockwood, Alan L.
    Blennow, Kaj
    Strathmann, Frederick G.
    Hanrieder, Jorg
    CLINICAL MASS SPECTROMETRY, 2019, 14 : 124 - 129
  • [26] Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's Disease
    Ferrero, Hilda
    Larrayoz, Ignacio M.
    Martisova, Eva
    Solas, Maite
    Howlett, David R.
    Francis, Paul T.
    Gil-Bea, Francisco J.
    Martinez, Alfredo
    Ramirez, Maria J.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5177 - 5183
  • [27] Brain vasopressin levels in Down syndrome and Alzheimer's disease
    Labudova, O
    Fang-Kircher, S
    Cairns, N
    Moenkemann, H
    Yeghiazaryan, K
    Lubec, G
    BRAIN RESEARCH, 1998, 806 (01) : 55 - 59
  • [28] Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
    Hellstrom-Lindahl, E.
    Viitanen, M.
    Marutle, A.
    NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (04) : 243 - 252
  • [29] Methionine and cystathionine levels in the brain of patients with Alzheimer's disease
    Gueli, MC
    Guglielmini, E
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 29 - 29
  • [30] Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease
    Hilda Ferrero
    Ignacio M. Larrayoz
    Eva Martisova
    Maite Solas
    David R. Howlett
    Paul T. Francis
    Francisco J. Gil-Bea
    Alfredo Martínez
    María J. Ramírez
    Molecular Neurobiology, 2018, 55 : 5177 - 5183